Research suggests mucopolysaccharidosis patients may be less vulnerable to COVID-19

Researchers at the University of GdaƄsk, Poland have conducted tests that show certain genes in the DNA of MPS patients render their cells less susceptible to COVID-19 infection than normal cells, though the typical – for storage diseases – narrowing of the respiratory tract and presence of thick mucous are still risk factors for infection. The full text of the article is available here